Lite Strategy, Inc. also files under LITS, MSHL; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 24, 2026 | Flynn James P | Director | Buy(P) | 25K | $0.86 | $21K |
| Feb 12, 2026 | File Justin J. | CEO, CFO and Secretary, Director | Grant(A) | 455K | — | — |
| Dec 19, 2025 | Flynn James P | Director | Buy(P) | 70K | $1.40 | $98K |
| Dec 18, 2025 | Schornstein Alexander | 10% Owner | Sell(S) | 691K | $1.37 | $946K |
| Nov 19, 2025 | Flynn James P | Director | Buy(P) | 12K | $1.88 | $23K |
| Nov 14, 2025 | Riezman Joshua | Director | Grant(A) | 10K | — | — |
| Nov 14, 2025 | Riezman Joshua | Director | Grant(A) | 55K | — | — |
| Nov 14, 2025 | Flynn James P | Director | Grant(A) | 55K | — | — |
| Nov 14, 2025 | Glover Nicholas | Director | Grant(A) | 55K | — | — |
| Nov 14, 2025 | File Justin J. | CEO, CFO and Secretary, Director | Grant(A) | 180K | — | — |
| Nov 14, 2025 | Driscoll Frederick W | Director | Grant(A) | 55K | — | — |
| Oct 3, 2025 | Lee Charles Benjamin | Director | Grant(A) | 10K | — | $0 |
| Sep 30, 2025 | Flynn James P | Director | Grant(A) | 10K | $2.54 | $25K |
| Aug 8, 2025 | Riezman Joshua | Director | Grant(A) | 10K | — | $0 |
| Jul 15, 2025 | Wood Steven D | Director | Grant(A) | 20K | — | $0 |
| Jul 15, 2025 | Flynn James P | Director | Grant(A) | 20K | — | $0 |
| Jul 15, 2025 | File Justin J. | Secretary, Acting CEO & CFO | Grant(A) | 20K | — | $0 |
| Jul 15, 2025 | Driscoll Frederick W | Director | Grant(A) | 20K | — | $0 |
| Jul 15, 2025 | Glover Nicholas | Director | Grant(A) | 20K | — | $0 |
| Jul 15, 2025 | Reynolds Thomas C | Director | Grant(A) | 20K | — | $0 |
| May 17, 2024 | Wood Steven D | Director | Grant(A) | 3K | $3.17 | $10K |
| May 16, 2024 | Flynn James P | Director | Grant(A) | 8K | $3.16 | $25K |
| Dec 18, 2023 | Flynn James P | Director | Grant(A) | 7K | — | $0 |
| Dec 18, 2023 | Wood Steven D | Director | Grant(A) | 10K | — | $0 |
| Dec 18, 2023 | Flynn James P | Director | Grant(A) | 10K | — | $0 |
| Dec 18, 2023 | Wood Steven D | Director | Grant(A) | 7K | — | $0 |
| Oct 20, 2023 | Funicular Funds, LP | 10% Owner | Option exercise(X) | 1K | — | $0 |
| Oct 20, 2023 | Funicular Funds, LP | 10% Owner | Expiration(E) | 4K | — | $0 |
| Oct 20, 2023 | Kassam Moez | 10% Owner | Option exercise(X) | 36K | $7.00 | $251K |
| Oct 20, 2023 | Kassam Moez | 10% Owner | Option exercise(X) | 1K | — | $0 |
| Oct 20, 2023 | Kassam Moez | 10% Owner | Option exercise(X) | 358 | — | $0 |
| Oct 20, 2023 | Funicular Funds, LP | 10% Owner | Option exercise(X) | 121K | $7.00 | $844K |
| Oct 20, 2023 | Kassam Moez | 10% Owner | Option exercise(X) | 143K | $7.00 | $1.0M |
| Oct 20, 2023 | Kassam Moez | 10% Owner | Expiration(E) | 7K | — | $0 |
| Oct 11, 2023 | Ma-Weaver Jacob | 10% Owner | Option exercise(X) | 300 | — | $0 |
| Oct 11, 2023 | Ma-Weaver Jacob | 10% Owner | Option exercise(X) | 30K | $7.00 | $210K |
| Oct 11, 2023 | Anson Funds Management LP | 10% Owner | Option exercise(X) | 100 | — | $0 |
| Oct 11, 2023 | Anson Funds Management LP | 10% Owner | Option exercise(X) | 400 | — | $0 |
| Oct 11, 2023 | Anson Funds Management LP | 10% Owner | Option exercise(X) | 10K | $7.00 | $70K |
| Oct 11, 2023 | Anson Funds Management LP | 10% Owner | Option exercise(X) | 40K | $7.00 | $280K |
| Sep 29, 2023 | Baltic Charles V. III | Director | Grant(A) | 10K | — | $0 |
| Sep 29, 2023 | Ghalie Richard G | Chief Medical Officer | Grant(A) | 30K | — | $0 |
| Sep 29, 2023 | Driscoll Frederick W | Director | Grant(A) | 10K | — | $0 |
| Sep 29, 2023 | Gold Daniel P PHD | Director | Grant(A) | 10K | — | $0 |
| Sep 29, 2023 | Reynolds Thomas C | Director | Grant(A) | 10K | — | $0 |
| Sep 29, 2023 | Glover Nicholas | Director | Grant(A) | 10K | — | $0 |
| Sep 29, 2023 | Howson Tamar D | Director | Grant(A) | 10K | — | $0 |
| Sep 29, 2023 | Kango Sujay | Director | Grant(A) | 10K | — | $0 |
| Sep 22, 2023 | Ma-Weaver Jacob | 10% Owner | Buy(P) | 32K | $6.85 | $219K |
| Sep 22, 2023 | Winson Bruce Ross | 10% Owner | Buy(P) | 48K | $6.85 | $329K |
| Sep 22, 2023 | Winson Bruce Ross | 10% Owner | Sell(S) | 9K | $0.15 | $1K |
| Sep 22, 2023 | Ma-Weaver Jacob | 10% Owner | Sell(S) | 6K | $0.14 | $840 |
| Sep 21, 2023 | Kassam Moez | 10% Owner | Buy(P) | 34K | $6.46 | $217K |
| Sep 21, 2023 | Ma-Weaver Jacob | 10% Owner | Buy(P) | 22K | $6.46 | $145K |
| Sep 20, 2023 | Kassam Moez | 10% Owner | Buy(P) | 120K | $6.01 | $721K |
| Sep 20, 2023 | Ma-Weaver Jacob | 10% Owner | Buy(P) | 80K | $6.01 | $481K |
| Jun 2, 2023 | Urso David M | President and CEO, Director | Grant(A) | 167K | — | $0 |
| Feb 28, 2023 | Baltic Charles V. III | Director | Buy(P) | 82K | $0.23 | $19K |
| Jul 5, 2022 | Cohen Cheryl | Director | Grant(A) | 88K | — | $0 |
| Jul 5, 2022 | Gold Daniel P PHD | Chief Executive Officer, Director | Grant(A) | 1.5M | — | $0 |
| Jul 5, 2022 | Drazba Brian G. | Chief Financial Officer | Grant(A) | 350K | — | $0 |
| Jul 5, 2022 | Reynolds Thomas C | Director | Grant(A) | 88K | — | $0 |
| Jul 5, 2022 | White Christine Anna | Director | Grant(A) | 88K | — | $0 |
| Jul 5, 2022 | Howson Tamar D | Director | Grant(A) | 88K | — | $0 |
| Jul 5, 2022 | Urso David M | Chief Operating Officer & GC | Grant(A) | 1.1M | — | $0 |
| Jul 5, 2022 | Glover Nicholas | Director | Grant(A) | 88K | — | $0 |
| Jul 5, 2022 | Kango Sujay | Director | Grant(A) | 88K | — | $0 |
| Jul 5, 2022 | Ghalie Richard G | Chief Medical Officer | Grant(A) | 560K | — | $0 |
| Jul 5, 2022 | Ghalie Richard G | Chief Medical Officer | Tax withholding(F) | 8K | $0.54 | $4K |
| Jul 5, 2022 | Baltic Charles V. III | Director | Grant(A) | 88K | — | $0 |
| Jul 5, 2022 | Driscoll Frederick W | Director | Grant(A) | 88 | — | $0 |
| Nov 22, 2021 | Kango Sujay | Director | Grant(A) | 58K | — | $0 |
| Jul 2, 2021 | Urso David M | Chief Operating Officer & GC | Tax withholding(F) | 25K | $2.94 | $73K |
| Jul 2, 2021 | Gold Daniel P PHD | Chief Executive Officer, Director | Tax withholding(F) | 41K | $2.94 | $121K |
| Jul 1, 2021 | Urso David M | Chief Operating Officer & GC | Grant(A) | 600K | — | $0 |
| Jul 1, 2021 | Gold Daniel P PHD | Chief Executive Officer, Director | Grant(A) | 855K | — | $0 |
| Jul 1, 2021 | Howson Tamar D | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2021 | Reynolds Thomas C | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2021 | Cohen Cheryl | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2021 | Glover Nicholas | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2021 | Driscoll Frederick W | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2021 | Clemens Kevan | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2021 | Baltic Charles V. III | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2021 | Ghalie Richard G | Chief Medical Officer | Grant(A) | 320K | — | $0 |
| Jul 1, 2021 | Drazba Brian G. | Chief Financial Officer | Grant(A) | 200K | — | $0 |
| Jul 1, 2021 | White Christine Anna | Director | Grant(A) | 50K | — | $0 |
| May 25, 2021 | Gold Daniel P PHD | Chief Executive Officer, Director | Option exercise(M) | 5K | $2.52 | $13K |
| May 25, 2021 | Gold Daniel P PHD | Chief Executive Officer, Director | Option exercise(M) | 5K | — | $0 |
| May 3, 2021 | Ghalie Richard G | Chief Medical Officer | Grant(A) | 75K | — | $0 |
| Feb 23, 2021 | Driscoll Frederick W | Director | Sell(S) | 25K | $4.03 | $101K |
| Jul 23, 2020 | Gold Daniel P PHD | Chief Executive Officer, Director | Option exercise(M) | 12K | $1.57 | $19K |
| Jul 23, 2020 | Gold Daniel P PHD | Chief Executive Officer, Director | Option exercise(M) | 12K | — | $0 |
| Jul 2, 2020 | Urso David M | Chief Operating Officer & GC | Grant(A) | 525K | — | $0 |
| Jul 2, 2020 | Urso David M | Chief Operating Officer & GC | Grant(A) | 50K | — | $0 |
| Jul 2, 2020 | Mass Robert D. | Chief Medical Officer | Grant(A) | 230K | — | $0 |
| Jul 2, 2020 | Howson Tamar D | Director | Grant(A) | 50K | — | $0 |
| Jul 2, 2020 | Drazba Brian G. | Chief Financial Officer | Grant(A) | 230K | — | $0 |
| Jul 2, 2020 | Clemens Kevan | Director | Grant(A) | 50K | — | $0 |
| Jul 2, 2020 | Baltic Charles V. III | Director | Grant(A) | 50K | — | $0 |
| Jul 2, 2020 | Gold Daniel P PHD | Chief Executive Officer, Director | Grant(A) | 680K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Lite Strategy, Inc., SEC CIK 0001262104. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under MEIP and shows every filing by that issuer (also filed as LITS, MSHL).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for MEIP